Sami Qadri

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

John O'Sullivan

Professor of Cardiometabolic Medicine

University of Sydney

AUSTRALIA

View details

Maija Ruuth

University of Helsinki

FINLAND

View details

Taru Tukiainen

Associate Professor

University of Eastern Finland

FINLAND

View details

Martti Färkkilä

University of Helsinki

FINLAND

View details

Hannele Yki-Järvinen

Helsinki University Hospital

FINLAND

View details

Jussi Pihlajamäki

University of Eastern Finland

FINLAND

View details

Marcus Höring

University Hospital Regensburg

GERMANY

View details

Tiina Vesterinen

University of Helsinki

FINLAND

View details

Katariina Öörni

University of Helsinki

FINLAND

View details

Taina Sipponen

University of Helsinki

FINLAND

View details

Umberto Vespasiani‐Gentilucci

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sami Qadri

Research Interests

Explore related searches

Contact this professor

Articles (16)

Surveillance of the liver in type 2 diabetes: important but unfeasible?

The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease

<i>SIRT5 </i>rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: an International Study With 1924 Patients

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles

Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease

The quest for the missing links in fatty liver genetics: Deep learning to the rescue!

Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes

Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Collaborators (11)

John O'Sullivan

Maija Ruuth

Taru Tukiainen

Martti Färkkilä

Hannele Yki-Järvinen

Jussi Pihlajamäki

Marcus Höring

Tiina Vesterinen

Katariina Öörni

Taina Sipponen

Umberto Vespasiani‐Gentilucci

Make your next move.

Sami Qadri

Research Interests

Explore related searches

Contact this professor

Articles (16)

Surveillance of the liver in type 2 diabetes: important but unfeasible?

The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease

<i>SIRT5 </i>rs12216101 T&gt;G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease

IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids

Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: an International Study With 1924 Patients

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles

Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease

The quest for the missing links in fatty liver genetics: Deep learning to the rescue!

Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes

Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Collaborators (11)

John O'Sullivan

Maija Ruuth

Taru Tukiainen

Martti Färkkilä

Hannele Yki-Järvinen

Jussi Pihlajamäki

Marcus Höring

Tiina Vesterinen

Katariina Öörni

Taina Sipponen

Umberto Vespasiani‐Gentilucci

Make your next move.

<i>SIRT5 </i>rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease